Entrada Therapeutics, Inc.

TRDA·NASDAQ·$6.70Share Price as of 11/2·$260MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/06/25

Disclosures

8-KCurrent report10/14/26 8-KCurrent report08/05/26 8-KCurrent report06/10/26 8-KCurrent report05/19/26 8-KCurrent report05/07/26

Prospectuses and Registrations

S-8Registration of securities for employees02/26/26 S-3Shelf registration11/06/25 S-8Registration of securities for employees03/25/25 S-8Registration of securities for employees02/27/25 424B5Prospectus supplement06/24/24

Proxies

DEFA14AAdditional proxy materials04/29/26 DEF 14ADefinitive proxy04/24/26 DEFA14AAdditional proxy materials04/24/26 DEFA14AAdditional proxy materials06/03/25 DEF 14ADefinitive proxy04/25/25

Ownership

SC 13D/ABeneficial ownership (amended)09/10/26 Form 4Insider transaction09/09/26 Form 4Insider transaction09/09/26 Form 4Insider transaction09/03/26 Form 4Insider transaction09/03/26

Other

ARSAnnual report to shareholders04/24/26 EFFECTRequest for effectiveness12/03/25 CORRESPCorrespondence with the SEC12/01/25 ARSAnnual report to shareholders04/25/25 ARSAnnual report to shareholders04/29/24